KPIs & Operating Metrics(New)
Growth Metrics

Stryker (SYK) Shares Outstanding (Diluted Average) (2009 - 2026)

Stryker (SYK) reported Shares Outstanding (Diluted Average) of $386.5 million for Q1 2026, little changed year-over-year from $386.4 million in Q1 2025, and little changed on a QoQ basis from $386.5 million in Q4 2025.

Stryker (SYK) has 18 years of Shares Outstanding (Diluted Average) data on file, last reported at $386.5 million in Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) changed 0.03% year-over-year to $386.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $386.5 million (changed 0.03% YoY) and the FY2025 annual result came in at $386.5 million, up 8302.17% from the prior year.
  • Shares Outstanding (Diluted Average) held at $386.5 million in Q1 2026 per SYK's latest filing, from $386.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $386.5 million in Q4 2025 and bottomed at $4.0 million in Q4 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $382.5 million (2022), against an average of $227.9 million.
  • The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) soared 9492.5%; it then sank 98.88% in 2025.
  • Tracing SYK's Shares Outstanding (Diluted Average) over 5 years: stood at $4.0 million in 2022, then soared by 9492.5% to $383.7 million in 2023, then plunged by 98.8% to $4.6 million in 2024, then jumped by 8302.17% to $386.5 million in 2025, then changed by 0.0% to $386.5 million in 2026.
  • Per Business Quant, the three latest SYK Shares Outstanding (Diluted Average) figures stand at $386.5 million (Q1 2026), $386.5 million (Q4 2025), and $4.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.75 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 386.50 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 457.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 386.50 Mn
Dec 31, 2025 386.50 Mn
Sep 30, 2025 4.30 Mn
Jun 30, 2025 4.20 Mn
Mar 31, 2025 386.40 Mn
Dec 31, 2024 4.60 Mn
Sep 30, 2024 385.40 Mn
Jun 30, 2024 4.40 Mn
Mar 31, 2024 4.70 Mn
Dec 31, 2023 383.70 Mn
Sep 30, 2023 384.00 Mn
Jun 30, 2023 383.60 Mn
Mar 31, 2023 383.20 Mn
Dec 31, 2022 4.00 Mn
Sep 30, 2022 381.80 Mn
Jun 30, 2022 382.50 Mn
Mar 31, 2022 5.00 Mn
Dec 31, 2021 5.30 Mn
Sep 30, 2021 5.60 Mn
Jun 30, 2021 5.40 Mn
Mar 31, 2021 381.70 Mn
Dec 31, 2020 4.80 Mn
Sep 30, 2020 380.20 Mn
Jun 30, 2020 4.80 Mn
Mar 31, 2020 4.90 Mn
Dec 31, 2019 379.90 Mn
Sep 30, 2019 6.10 Mn
Jun 30, 2019 5.60 Mn
Mar 31, 2019 6.00 Mn
Dec 31, 2018 380.30 Mn
Sep 30, 2018 6.40 Mn
Jun 30, 2018 380.10 Mn
Mar 31, 2018 6.70 Mn
Dec 31, 2017 6.10 Mn
Sep 30, 2017 379.80 Mn
Jun 30, 2017 5.90 Mn
Mar 31, 2017 5.90 Mn
Dec 31, 2016 4.40 Mn
Sep 30, 2016 4.60 Mn
Jun 30, 2016 378.50 Mn
Mar 31, 2016 377.40 Mn
Dec 31, 2015 380.90 Mn
Sep 30, 2015 380.70 Mn
Jun 30, 2015 4.30 Mn
Mar 31, 2015 383.50 Mn
Dec 31, 2014 4.30 Mn
Sep 30, 2014 382.70 Mn
Jun 30, 2014 382.70 Mn
Mar 31, 2014 382.60 Mn
Dec 31, 2013 382.10 Mn
Sep 30, 2013 381.70 Mn
Jun 30, 2013 381.00 Mn
Mar 31, 2013 383.00 Mn
Dec 31, 2012 2.40 Mn
Sep 30, 2012 2.50 Mn
Jun 30, 2012 2.50 Mn
Mar 31, 2012 2.80 Mn
Dec 31, 2011 389.50 Mn
Sep 30, 2011 388.40 Mn
Jun 30, 2011 4.00 Mn
Mar 31, 2011 394.20 Mn
Dec 31, 2010 399.50 Mn
Sep 30, 2010 399.00 Mn
Jun 30, 2010 399.70 Mn
Mar 31, 2010 400.10 Mn
Dec 31, 2009 399.40 Mn
Sep 30, 2009 399.60 Mn
Jun 30, 2009 399.00 Mn
Mar 31, 2009 398.60 Mn